Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1Phase 1/2 1

Status

Completed 10Unknown 5Terminated 4Withdrawn 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Glioma 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × OTHER × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all
NCT03730948 2024-05-24

DC Vaccine in Colorectal Cancer

University of Pennsylvania

Phase 1 Terminated
4 enrolled 6 charts
Gastrointestinal

Colorectal Neoplasms

NCT02543749 2023-02-09

DC Vaccination in CML

Charite University, Berlin, Germany

Phase 1/2 Terminated
1 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01902771 2017-03-10

Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors

University of Miami

Phase 1 Terminated
1 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT00913913 2015-12-01

Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

Dartmouth-Hitchcock Medical Center

Phase 2 Terminated
8 enrolled 10 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡